1Bours V, Dejardin E, Goujon-Letawe F, et al. The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol,1994, 47:145-149.
2Corv AH, Cory JG . Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells. Anticancer Res, 2002, 22(6C):3805-3809.
3Bartke T, Siegmund D, Peters N, et al. p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene, 2001,20:571-580.
4Jin SH, Kim TI, Han DS,et al. Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells.Ann N Y Acad Sci, 2002, 973:414-418.
5Hong JJ, Jeong TS, Choi JH ,et al. Hematein inhibits tumor necrotic factor-alpha-induced vascular cell adhesion molecule-1 and NF-kappaB-dependent gene expression in human vascular endothelial cells. Biochem Biophys Res Commun, 2001,281:1127-1133.
6Zingarelli B, Sheehan M, Wong HR.Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med, 2003,31:105-110.
7Porcile C, Piccioli P, Stanzione S,et al. Proteasome inhibitors induce cerebellar granule cell death: inhibition of nuclear factor-kB activation. Ann N Y Acad Sci,2002, 973:402-413.
8Shao J, Fujiwara T, Kadowaki Y, et al. Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene, 2000, 19:726-736.
9Pather S,Quinn MA.Clear-cell cancer of the ovary-is it chemosensitive[J].Int J Gynecol Cancer,2005,15(3):432-437.
10Matsuura Y,Robertson G,Marsden DE,et al.Thromboembolic complications in patients with clear cell carcinoma of the ovary[J].Gynecol Oncol,2007,104(2):406-410.
